Fractyl Health, Inc. Common Stock - gráfico, preços e notícias (NASDAQ:GUTS)

Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas

Trimestral Ano

Market Capitalization 128.51 M
Employee 73
Founded 2010
CEO N/A
Website www.fractyl.com
Headquarter Delaware, United States
FIGI BBG002Y7NH72
Industry Biotecnologia

Receita total

Lucro líquido

Lucro básico por ação

Dívida total

Fluxo de caixa livre

Caixa e equivalentes de caixa

Índice preço/lucro

-1.18

Índice preço/fluxo de caixa

—

Fractyl Health, Inc. - Common Stock

Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.

GUTS

Financials

Fractyl Health, Inc. - Common Stock

Notícias

Fractyl Health, Inc. (GUTS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Fractyl Health, Inc. (GUTS) Q1 2026 Earnings Call Transcript

Fractyl Health recebe aprovação para ensaio clínico de terapia gênica para diabetes

Fractyl Health, Inc. (GUTS) Q4 2025 Earnings Call Transcript

Fractyl Health reduz custos no 4º tri de 2025, mas ações caem

Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Fractyl Health: Low Market Expectations Create Trading Opportunity With 2026 Catalysts

Morgan Stanley rebaixa Fractyl Health para Equalweight após resultados do estudo Revita

Morgan Stanley downgrades Fractyl Health stock rating to Equalweight on Revita trial results

E.U.A. - Ações fecharam o pregão inalteradas e o Índice Dow Jones Industrial Average avançou 0,11%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11%

Why Is Fractyl Health Stock Tumbling Today? - Fractyl Health (NASDAQ:GUTS)